HK1257630A1 - 鑑定用於減輕和/或治療與異常星形細胞功能相關的疾病的化合物的方法 - Google Patents

鑑定用於減輕和/或治療與異常星形細胞功能相關的疾病的化合物的方法

Info

Publication number
HK1257630A1
HK1257630A1 HK18116758.8A HK18116758A HK1257630A1 HK 1257630 A1 HK1257630 A1 HK 1257630A1 HK 18116758 A HK18116758 A HK 18116758A HK 1257630 A1 HK1257630 A1 HK 1257630A1
Authority
HK
Hong Kong
Prior art keywords
mitigating
abnormal
identifying
treatment
disease associated
Prior art date
Application number
HK18116758.8A
Other languages
English (en)
Inventor
Toma M Zorec
Original Assignee
Celica Biomedical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celica Biomedical filed Critical Celica Biomedical
Publication of HK1257630A1 publication Critical patent/HK1257630A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C10/00—Computational theoretical chemistry, i.e. ICT specially adapted for theoretical aspects of quantum chemistry, molecular mechanics, molecular dynamics or the like
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Computing Systems (AREA)
  • Theoretical Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK18116758.8A 2015-10-06 2018-12-31 鑑定用於減輕和/或治療與異常星形細胞功能相關的疾病的化合物的方法 HK1257630A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15188662 2015-10-06
PCT/EP2016/073904 WO2017060367A1 (en) 2015-10-06 2016-10-06 Method for identifying a compound useful in mitigating and/or the treatment of a disease associated with abnormal astrocytic function

Publications (1)

Publication Number Publication Date
HK1257630A1 true HK1257630A1 (zh) 2019-10-25

Family

ID=54293083

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18116758.8A HK1257630A1 (zh) 2015-10-06 2018-12-31 鑑定用於減輕和/或治療與異常星形細胞功能相關的疾病的化合物的方法

Country Status (4)

Country Link
US (1) US11231410B2 (zh)
EP (1) EP3341731B1 (zh)
HK (1) HK1257630A1 (zh)
WO (1) WO2017060367A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6991092B2 (ja) * 2018-03-29 2022-01-12 大阪瓦斯株式会社 睡眠の質改善剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2818177A1 (en) * 2013-06-24 2014-12-31 Celica, D.O.O. Mechanism and drug targets for reducing cell edema (neuroprotection) and cytoplasmic excitability in astrocytes in normal and pathological states

Also Published As

Publication number Publication date
EP3341731A1 (en) 2018-07-04
US20180284101A1 (en) 2018-10-04
US11231410B2 (en) 2022-01-25
EP3341731B1 (en) 2020-01-29
WO2017060367A1 (en) 2017-04-13

Similar Documents

Publication Publication Date Title
IL262225A (en) Methods for monitoring and treating cancer
GB2544946B (en) Systems and methods for analyzing the eye
EP3634442A4 (en) METHODS OF TREATMENT AND PREVENTION OF DISEASES
EP3131931A4 (en) Methods for increasing red blood cell levels and treating sickle-cell disease
ZA201607536B (en) Arrangement and method for identifying fingerprints
EP3212137A4 (en) Systems and methods for the treatment of eye conditions
EP3107642A4 (en) Systems and methods for treating blood
IL262223A (en) Methods for monitoring and treating cancer
IL266454B (en) Implant and method of creating the implant
EP3113734A4 (en) Device and method for sleep apnoea treatment
TWI560575B (en) Microprocessor and method for securely executing instructions therein
HK1245444A1 (zh) 計算機執行系統及識別類似患者的方法
EP3182990A4 (en) Methods and compositions for treating and/or preventing a disease or disorder associated with abnormal level and/or activity of the ifp35 family of proteins
EP3330974C0 (en) SYSTEM AND METHOD FOR PHYSIOLOGICAL MONITORING
IL252904A0 (en) Methods and factors for treating diseases
PL3187905T3 (pl) System kontroli bezpieczeństwa ciała ludzkiego oraz sposób kontroli bezpieczeństwa ciała ludzkiego przeprowadzany przy użyciu systemu
EP3297728A4 (en) METHODS FOR DIAGNOSING AND EVALUATING TREATMENT OF CUSHING SYNDROME
HK1257630A1 (zh) 鑑定用於減輕和/或治療與異常星形細胞功能相關的疾病的化合物的方法
EP3481432A4 (en) DIAGNOSIS OF DISEASES ASSOCIATED WITH THE COL6 GENE AND RELATED METHODS OF TREATMENT
EP3302684A4 (en) METHOD AND DEVICES FOR TREATING THE CORNEA
EP3307775A4 (en) Methods for diagnosing and treating affective disorders
EP3373947A4 (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN
SG10201601639WA (en) Processed egg and method for identifying the same
IL255012A0 (en) Preparations and methods for treating skin conditions
GB201617715D0 (en) Methods for the treatment and prevention of ebola